Total Payments
$4,179
2024 Payments
$303.97
Companies
22
Transactions
134
Medicare Patients
9,046
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$4,172 (99.8%)
Education$7.36 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,172 | 132 | 99.8% |
| Education | $7.36 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $585.00 | 10 | $0 (2024) |
| GlaxoSmithKline, LLC. | $549.58 | 18 | $0 (2024) |
| Lilly USA, LLC | $441.33 | 20 | $0 (2023) |
| Abbott Laboratories | $441.25 | 10 | $0 (2023) |
| Novo Nordisk Inc | $323.78 | 14 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $262.44 | 4 | $0 (2024) |
| ABBVIE INC. | $170.87 | 5 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $164.23 | 4 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $155.61 | 8 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $147.31 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $303.97 | 13 | Amgen Inc. ($84.10) |
| 2023 | $272.33 | 8 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2022 | $999.32 | 16 | Amgen Inc. ($407.24) |
| 2021 | $211.91 | 7 | AbbVie Inc. ($85.87) |
| 2020 | $239.50 | 14 | GlaxoSmithKline, LLC. ($88.14) |
| 2019 | $1,062 | 24 | GlaxoSmithKline, LLC. ($222.19) |
| 2018 | $466.27 | 23 | GlaxoSmithKline, LLC. ($144.55) |
| 2017 | $624.05 | 29 | Novo Nordisk Inc ($164.33) |
All Payment Transactions
134 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $29.99 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: Inflammation | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $26.33 | General |
| 10/15/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: RESPIRATORY | ||||||
| 09/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $28.94 | General |
| Category: RESPIRATORY | ||||||
| 07/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Diabetes | ||||||
| 07/03/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.58 | General |
| 06/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: NEUROSCIENCE | ||||||
| 05/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $31.98 | General |
| Category: Inflammation | ||||||
| 04/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: Inflammation | ||||||
| 03/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: NEUROSCIENCE | ||||||
| 01/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 07/18/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Diabetes Care | ||||||
| 05/02/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $28.43 | General |
| Category: Diabetes | ||||||
| 04/07/2023 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/04/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Diabetes Care | ||||||
| 04/04/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Diabetes Care | ||||||
| 01/17/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: DIABETES | ||||||
| 12/13/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.86 | General |
| Category: Inflammation | ||||||
| 11/21/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $7.13 | General |
| Category: Diabetes Care | ||||||
| 11/17/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiology | ||||||
| 10/18/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $10.25 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 2,286 | 4,080 | $582,586 | $389,942 |
| 2022 | 23 | 2,101 | 3,647 | $489,616 | $330,934 |
| 2021 | 32 | 2,642 | 4,363 | $503,041 | $342,826 |
| 2020 | 24 | 2,017 | 3,365 | $393,203 | $235,070 |
Total Patients
9,046
Total Services
15,455
Medicare Billing
$1.3M
Procedure Codes
104
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 526 | 1,736 | $297,745 | $195,138 | 65.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 361 | 361 | $63,225 | $57,713 | 91.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 211 | 393 | $54,920 | $29,354 | 53.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 180 | 320 | $40,000 | $21,369 | 53.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 93 | 123 | $28,895 | $20,298 | 70.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 47 | 59 | $16,225 | $11,820 | 72.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 132 | 132 | $12,540 | $9,419 | 75.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 28 | 28 | $9,250 | $7,892 | 85.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 18 | 22 | $8,075 | $6,077 | 75.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 139 | 139 | $5,720 | $5,238 | 91.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 36 | 47 | $7,755 | $5,080 | 65.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 26 | 26 | $5,850 | $5,053 | 86.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $6,104 | $2,921 | 47.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $3,150 | $2,837 | 90.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 152 | 246 | $3,444 | $2,050 | 59.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 49 | 49 | $1,985 | $1,857 | 93.6% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 27 | 31 | $2,015 | $1,559 | 77.4% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 26 | 27 | $2,781 | $1,052 | 37.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 14 | 14 | $3,024 | $837.33 | 27.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 44 | 54 | $5,400 | $765.07 | 14.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 33 | 46 | $1,610 | $633.18 | 39.3% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 12 | 13 | $1,105 | $567.74 | 51.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 51 | 67 | $1,073 | $228.47 | 21.3% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 14 | 25 | $275.00 | $119.36 | 43.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 29 | 84 | $420.00 | $64.12 | 15.3% |
About Dr. Kenneth Jiang, MD
Dr. Kenneth Jiang, MD is a Internal Medicine healthcare provider based in Hollister, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841279841.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Jiang, MD has received a total of $4,179 in payments from pharmaceutical and medical device companies, with $303.97 received in 2024. These payments were reported across 134 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($4,172).
As a Medicare-enrolled provider, Jiang has provided services to 9,046 Medicare beneficiaries, totaling 15,455 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Hollister, CA
- Active Since 01/10/2006
- Last Updated 02/11/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1841279841
Products in Payments
- TRELEGY ELLIPTA (Drug) $381.00
- FREESTYLE LIBRE 2 (Device) $380.22
- TRULICITY (Drug) $333.15
- Repatha (Biological) $262.09
- Otezla (Drug) $229.25
- TOUJEO (Drug) $164.23
- JARDIANCE (Drug) $162.32
- ENTRESTO (Drug) $147.31
- Tresiba (Drug) $138.67
- XARELTO (Drug) $127.73
- BREZTRI (Drug) $125.00
- Tirosint (Drug) $124.98
- Ozempic (Drug) $117.31
- Vascepa (Drug) $116.85
- JANUVIA (Drug) $104.10
- FARXIGA (Drug) $96.53
- EVENITY (Biological) $93.66
- Trintellix (Drug) $89.95
- ANORO ELLIPTA (Drug) $88.14
- ELIQUIS (Drug) $86.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Hollister
Narinder Gill, Md, MD
Internal Medicine — Payments: $558.43
Internal Medicine $558.43
Dr. Martin Bress, Md, MD
Internal Medicine — Payments: $148.94
Internal Medicine $148.94
Dr. Elizabeth Stobbe, M.d, M.D
Internal Medicine — Payments: $88.40
Internal Medicine $88.40
Dr. R Randall Sukman, M.d, M.D
Internal Medicine
Internal Medicine